The DOI matches its Crossref record; 158 of the 158 references it cites were found in a registry or an index.
Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance
Open accessAbstract
Quinolone antimicrobials are widely used in clinical medicine and are the only current class of agents that directly inhibit bacterial DNA synthesis.Quinolones dually target DNA gyrase and topoisomerase IV binding to specific domains and conformations so as to block DNA strand passage catalysis and stabilize DNA -enzyme complexes that block the DNA replication apparatus and generate double breaks in DNA that underlie their bactericidal activity.Resistance has emerged with clinical use of these agents and is common in some bacterial pathogens.Mechanisms of resistance include mutational alterations in drug target affinity and efflux pump expression and acquisition of resistance-conferring genes.Resistance mutations in one or both of the two drug target enzymes are commonly in a localized domain of the GyrA and ParC subunits of gyrase and topoisomerase IV, respectively, and reduce drug binding to the enzyme-DNA complex.Other resistance mutations occur in regulatory genes that control the expression of native efflux pumps localized in the bacterial membrane(s).These pumps have broad substrate profiles that include other antimicrobials as well as quinolones.Mutations of both types can accumulate with selection pressure and produce highly resistant strains.Resistance genes acquired on plasmids confer low-level resistance that promotes the selection of mutational high-level resistance.Plasmid-encoded resistance is because of Qnr proteins that protect the target enzymes from quinolone action, a mutant aminoglycoside-modifying enzyme that also modifies certain quinolones, and mobile efflux pumps.Plasmids with these mechanisms often encode additional antimicrobial resistances and can transfer multidrug resistance that includes quinolones.Q uinolones have been used extensively for a wide range of clinical applications (Owens and Ambrose 2000; Kim and Hooper 2014).Nalidixic acid, a related naphthyridone structure and the first member of the class used clinically, was discovered by George Lesher as a byproduct of chloroquine synthesis in 1962.Its use was limited to treatment of urinary tract infections and resistance emerged quickly (Lesher et al. 1962).Medicinal chemists from a number of companies, however, subsequently modified the core quinolone and related chemical scaffolds, generating compounds with greater potency, broader spectra of activity, improved pharmacokinetics, and lower frequency of development of resistance (Domagala and Hagen 2003).An important addition of a fluorine substituent at position 6 added to po-Editors: Lynn L. Silver and Karen Bush
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One major contributor to fluoroquinolone resistance is the emergence of mutations in the grlA and gyrA genes, which encode subunits of topoisomerase IV and DNA gyrase, the primary targets of fluoroquinolones [242].”
From Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms (2025) · cites this paper as [242]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, J. C. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.003223 · Cited by 1,832
The Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Mechanism of Quinolone Action and Resistance
Aldred, K. J., Kerns, R. J., & Osheroff, N. (2014) · Biochemistry · doi:10.1021/bi5000564 · Cited by 1,282
Quinolone resistance from a transferable plasmid
Martínez-Martínez, L., Pascual, A., & Jacoby, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07322-4 · Cited by 1,100
Self-citationFluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase
Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Hye Park, C., Bush, K., & Hooper, D. C. (2006) · Nature Medicine · doi:10.1038/nm1347 · Cited by 1,013
Self-citationEfflux-Mediated Drug Resistance in Bacteria: An Update
Li, X.-Z., & Nikaido, H. (2009) · Drugs · doi:10.2165/11317030-000000000-00000 · Cited by 966
Type IIA topoisomerase inhibition by a new class of antibacterial agents
Bax, B. D., Chan, P. F., Eggleston, D. S., Fosberry, A., Gentry, D. R., Gorrec, F., Giordano, I., Hann, M. M., Hennessy, A., Hibbs, M., et al. (2010) · Nature · doi:10.1038/nature09197 · Cited by 860
Efflux-Mediated Drug Resistance in Bacteria
Li, X.-Z., & Nikaido, H. (2004) · Drugs · doi:10.2165/00003495-200464020-00004 · Cited by 798
Molecular Properties of Bacterial Multidrug Transporters
Putman, M., van Veen, H. W., & Konings, W. N. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.672-693.2000 · Cited by 795
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M., & Nakamura, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1647 · Cited by 777
1,8-Naphthyridine Derivatives. A New Class of Chemotherapeutic Agents
Lesher, G. Y., Froelich, E. J., Gruett, M. D., Bailey, J. H., & Brundage, R. P. (1962) · Journal of Medicinal and Pharmaceutical Chemistry · doi:10.1021/jm01240a021 · Cited by 766
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.12.3322-3327.2000 · Cited by 722
Poole, K., Krebes, K., McNally, C., & Neshat, S. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.22.7363-7372.1993 · Cited by 688
Structure of the AcrAB–TolC multidrug efflux pump
Du, D., Wang, Z., James, N. R., Voss, J. E., Klimont, E., Ohene-Agyei, T., Venter, H., Chiu, W., & Luisi, B. F. (2014) · Nature · doi:10.1038/nature13205 · Cited by 662
Quinolones: from antibiotics to autoinducers
Heeb, S., Fletcher, M. P., Chhabra, S. R., Diggle, S. P., Williams, P., & Cámara, M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2010.00247.x · Cited by 595
Quinolone-Mediated Bacterial Death
Drlica, K., Malik, M., Kerns, R. J., & Zhao, X. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01617-06 · Cited by 570
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., & Nakamura, S. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.6.1271 · Cited by 570
Mechanism of plasmid-mediated quinolone resistance
Tran, J. H., & Jacoby, G. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082092899 · Cited by 564
Self-citationMechanisms of RND multidrug efflux pumps
Nikaido, H., & Takatsuka, Y. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.10.004 · Cited by 555
Ko¨hler, T., Michéa‐Hamzehpour, M., Henze, U., Gotoh, N., Kocjancic Curty, L., & Pechère, J. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.2281594.x · Cited by 549
CmeABC Functions as a Multidrug Efflux System in Campylobacter jejuni
Lin, J., Michel, L. O., & Zhang, Q. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2124-2131.2002 · Cited by 528
Plasmid-Mediated Quinolone Resistance
Jacoby, G. A., Strahilevitz, J., & Hooper, D. C. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.plas-0006-2013 · Cited by 479
Self-citationRosenberg, E. Y., Bertenthal, D., Nilles, M. L., Bertrand, K. P., & Nikaido, H. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03531.x · Cited by 468
Yamane, K., Wachino, J.-I., Suzuki, S., Kimura, K., Shibata, N., Kato, H., Shibayama, K., Konda, T., & Arakawa, Y. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00339-07 · Cited by 467
Crystal structure of the breakage–reunion domain of DNA gyrase
Cabral, J. H. M., Jackson, A. P., Smith, C. V., Shikotra, N., Maxwell, A., & Liddington, R. C. (1997) · Nature · doi:10.1038/42294 · Cited by 456
Poole, K., Gotoh, N., Tsujimoto, H., Zhao, Q., Wada, A., Yamasaki, T., Neshat, S., Yamagishi, J., Li, X., & Nishino, T. (1996) · Molecular Microbiology · doi:10.1046/j.1365-2958.1996.281397.x · Cited by 443
Cavaco, L. M., Hasman, H., Xia, S., & Aarestrup, F. M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00997-08 · Cited by 441
Regulation of bacterial drug export systems
Grkovic, S., Brown, M. H., & Skurray, R. A. (2002) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.66.4.671-701.2002 · Cited by 423
qnrB , Another Plasmid-Mediated Gene for Quinolone Resistance
Jacoby, G. A., Walsh, K. E., Mills, D. M., Walker, V. J., Oh, H., Robicsek, A., & Hooper, D. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1178-1182.2006 · Cited by 400
Self-citationThe mar regulon: multiple resistance to antibiotics and other toxic chemicals
Alekshun, M. N., & Levy, S. B. (1999) · Trends in Microbiology · doi:10.1016/s0966-842x(99)01589-9 · Cited by 395
Origin of Plasmid-Mediated Quinolone Resistance Determinant QnrA
Poirel, L., Rodriguez-Martinez, J.-M., Mammeri, H., Liard, A., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3523-3525.2005 · Cited by 394
Topoisomerase IV is a target of quinolones in Escherichia coli.
Khodursky, A. B., Zechiedrich, E. L., & Cozzarelli, N. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11801 · Cited by 378
Quinolones: Action and Resistance Updated
Drlica, K., Hiasa, H., Kerns, R., Malik, M., Mustaev, A., & Zhao, X. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789630947 · Cited by 376
Prevalence of Plasmid-Mediated Quinolone Resistance Determinants over a 9-Year Period
Kim, H. B., Park, C. H., Kim, C. J., Kim, E.-C., Jacoby, G. A., & Hooper, D. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01051-08 · Cited by 339
Self-citationKreuzer, K. N., & Cozzarelli, N. R. (1979) · Journal of Bacteriology · doi:10.1128/jb.140.2.424-435.1979 · Cited by 337
Wang, M., Guo, Q., Xu, X., Wang, X., Ye, X., Wu, S., Hooper, D. C., & Wang, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01400-08 · Cited by 324
Self-citationPoole, K., Tetro, K., Zhao, Q., Neshat, S., Heinrichs, D. E., & Bianco, N. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2021 · Cited by 324
Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance
Wohlkonig, A., Chan, P. F., Fosberry, A. P., Homes, P., Huang, J., Kranz, M., Leydon, V. R., Miles, T. J., Pearson, N. D., Perera, R. L., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1892 · Cited by 310
Structural insight into the quinolone–DNA cleavage complex of type IIA topoisomerases
Laponogov, I., Sohi, M. K., Veselkov, D. A., Pan, X.-S., Sawhney, R., Thompson, A. W., McAuley, K. E., Fisher, L. M., & Sanderson, M. R. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1604 · Cited by 304
MgrA Is a Multiple Regulator of Two New Efflux Pumps in Staphylococcus aureus
Truong-Bolduc, Q. C., Dunman, P. M., Strahilevitz, J., Projan, S. J., & Hooper, D. C. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.7.2395-2405.2005 · Cited by 296
Self-citationA Fluoroquinolone Resistance Protein from Mycobacterium tuberculosis That Mimics DNA
Hegde, S. S., Vetting, M. W., Roderick, S. L., Mitchenall, L. A., Maxwell, A., Takiff, H. E., & Blanchard, J. S. (2005) · Science · doi:10.1126/science.1110699 · Cited by 291
Cloning of a Novel Gene for Quinolone Resistance from a Transferable Plasmid in Shigella flexneri 2b
Hata, M., Suzuki, M., Matsumoto, M., Takahashi, M., Sato, K., Ibe, S., & Sakae, K. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.801-803.2005 · Cited by 287
Interaction of the Plasmid-Encoded Quinolone Resistance Protein Qnr with Escherichia coli DNA Gyrase
Tran, J. H., Jacoby, G. A., & Hooper, D. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.118-125.2005 · Cited by 283
Self-citationEmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB
Lomovskaya, O., Lewis, K., & Matin, A. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.9.2328-2334.1995 · Cited by 281
oqxAB Encoding a Multidrug Efflux Pump in Human Clinical Isolates of Enterobacteriaceae
Kim, H. B., Wang, M., Park, C. H., Kim, E.-C., Jacoby, G. A., & Hooper, D. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01574-08 · Cited by 271
Self-citationPérichon, B., Courvalin, P., & Galimand, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00143-07 · Cited by 266
Gill, M. J., Brenwald, N. P., & Wise, R. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.187 · Cited by 259
Hansen, L. H., Jensen, L. B., Sørensen, H. I., & Sørensen, S. J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm167 · Cited by 258
Fournier, B., & Hooper, D. C. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.14.3955-3964.2000 · Cited by 257
Self-citationYoon, E.-J., Courvalin, P., & Grillot-Courvalin, C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02556-12 · Cited by 256
Willmott, C. J., & Maxwell, A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.1.126 · Cited by 252
Luo, N., Sahin, O., Lin, J., Michel, L. O., & Zhang, Q. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.390-394.2003 · Cited by 251
Yu, E. W., Aires, J. R., McDermott, G., & Nikaido, H. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.19.6804-6815.2005 · Cited by 242
Fournier, B., Klier, A., & Rapoport, G. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02515.x · Cited by 242
Pan, X. S., & Fisher, L. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.471 · Cited by 237
Ng, E. Y., Trucksis, M., & Hooper, D. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1881 · Cited by 232
Self-citationLomovskaya, O., Lee, A., Hoshino, K., Ishida, H., Mistry, A., Warren, M. S., Boyer, E., Chamberland, S., & Lee, V. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.6.1340 · Cited by 220
DNA Gyrase and Topoisomerase IV Are Dual Targets of Clinafloxacin Action in Streptococcus pneumoniae
Pan, X.-S., & Fisher, L. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2810 · Cited by 215
Mechanism of quinolone inhibition of DNA gyrase
Shen, L. L., Kohlbrenner, W. E., Weigl, D., & Baranowski, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81708-8 · Cited by 214
An oxidation-sensing mechanism is used by the global regulator MgrA in Staphylococcus aureus
Chen, P. R., Bae, T., Williams, W. A., Duguid, E. M., Rice, P. A., Schneewind, O., & He, C. (2006) · Nature Chemical Biology · doi:10.1038/nchembio820 · Cited by 213
Yoon, E.-J., Nait Chabane, Y., Goussard, S., Snesrud, E., Courvalin, P., Dé, E., & Grillot-Courvalin, C. (2015) · mBio · doi:10.1128/mbio.00309-15 · Cited by 210
Alonso, A., & Martínez, J. L. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3079-3086.2000 · Cited by 207
Jacoby, G., Cattoir, V., Hooper, D., Martínez-Martínez, L., Nordmann, P., Pascual, A., Poirel, L., & Wang, M. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00147-08 · Cited by 202
Self-citationYu, E. W., Aires, J. R., & Nikaido, H. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.19.5657-5664.2003 · Cited by 191
Identification and characterization of porins in Pseudomonas aeruginosa.
Nikaido, H., Nikaido, K., & Harayama, S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35239-0 · Cited by 190
LmrS Is a Multidrug Efflux Pump of the Major Facilitator Superfamily from Staphylococcus aureus
Floyd, J. L., Smith, K. P., Kumar, S. H., Floyd, J. T., & Varela, M. F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00580-10 · Cited by 188
Blair, J. M. A., Bavro, V. N., Ricci, V., Modi, N., Cacciotto, P., Kleinekathӧfer, U., Ruggerone, P., Vargiu, A. V., Baylay, A. J., Smith, H. E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1419939112 · Cited by 186
Baucheron, S., Imberechts, H., Chaslus-Dancla, E., & Cloeckaert, A. (2002) · Microbial Drug Resistance · doi:10.1089/10766290260469543 · Cited by 186
NorM of Vibrio parahaemolyticus Is an Na + -Driven Multidrug Efflux Pump
Morita, Y., Kataoka, A., Shiota, S., Mizushima, T., & Tsuchiya, T. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.23.6694-6697.2000 · Cited by 179
Li, X.-Z., Zhang, L., & Poole, K. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.4.433 · Cited by 176
Fluoroquinolone-Gyrase-DNA Complexes
Mustaev, A., Malik, M., Zhao, X., Kurepina, N., Luan, G., Oppegard, L. M., Hiasa, H., Marks, K. R., Kerns, R. J., Berger, J. M., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.529164 · Cited by 172
Chou, J. H., Greenberg, J. T., & Demple, B. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.4.1026-1031.1993 · Cited by 171
Rat/MgrA, a Regulator of Autolysis, Is a Regulator of Virulence Genes in Staphylococcus aureus
Ingavale, S., van Wamel, W., Luong, T. T., Lee, C. Y., & Cheung, A. L. (2005) · Infection and Immunity · doi:10.1128/iai.73.3.1423-1431.2005 · Cited by 165
Ding, Y., Onodera, Y., Lee, J. C., & Hooper, D. C. (2008) · Journal of Bacteriology · doi:10.1128/jb.00655-08 · Cited by 164
Self-citationThe Mechanism of Inhibition of Topoisomerase IV by Quinolone Antibacterials
Khodursky, A. B., & Cozzarelli, N. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.42.27668 · Cited by 163
Pradel, E., & Pagès, J.-M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.8.2640-2643.2002 · Cited by 163
Bacterial Topoisomerases, Anti‐Topoisomerases, and Anti‐Topoisomerase Resistance
Hooper, D. C. (1998) · Clinical Infectious Diseases · doi:10.1086/514923 · Cited by 161
Self-citationQuinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus
Ito, H., Yoshida, H., Bogaki-Shonai, M., Niga, T., Hattori, H., & Nakamura, S. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2014 · Cited by 158
NorC, a New Efflux Pump Regulated by MgrA of Staphylococcus aureus
Truong, Q. C., Strahilevitz, J., & Hooper, D. C. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.3.1104-1107.2006 · Cited by 158
Self-citationZhao, J., Chen, Z., Chen, S., Deng, Y., Liu, Y., Tian, W. X., Huang, X., Wu, C., Sun, Y., Sun, Y., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00139-10 · Cited by 152
Quaternary changes in topoisomerase II may direct orthogonal movement of two DNA strands.
Berger, J. M., Fass, D., & Bogden, C. E. (1999) · Nature Structural Biology · doi:10.1038/7556 · Cited by 151
Novel Chromosomally Encoded Multidrug Efflux Transporter MdeA in Staphylococcus aureus
Huang, J., O’Toole, P. W., Shen, W., Amrine‐Madsen, H., Jiang, X., Lobo, N. A., Palmer, L. M., Voelker, L. L., Fan, F., Gwynn, M. N., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.909-917.2004 · Cited by 151
Vetting, M. W., Park, C. H., Hegde, S. S., Jacoby, G. A., Hooper, D. C., & Blanchard, J. S. (2008) · Biochemistry · doi:10.1021/bi800664x · Cited by 146
Self-citationVibrionaceae as a possible source of Qnr-like quinolone resistance determinants
Poirel, L., Liard, A., Rodríguez-Martínez, J. M., & Nordmann, P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki371 · Cited by 146
Zhang, L., Li, X.-Z., & Poole, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3497-3503.2001 · Cited by 143
Jair, K., Yu, X., Skarstad, K., et al. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.9.2507-2513.1996 · Cited by 139
Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus
Ubukata, K., Itoh-Yamashita, N., & Konno, M. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1535 · Cited by 139
Rodríguez-Martínez, J. M., de Alba, P. D., Briales, A., Machuca, J., Lossa, M., Fernández-Cuenca, F., Rodríguez‐Baño, J., Martínez-Martínez, L., & Pascual, Á. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks377 · Cited by 139
Schmitz, F., Jones, M. E., Hofmann, B., Hansen, B., Scheuring, S., Lückefahr, M., Fluit, A. C., Verhoef, J., Hadding, U., Heinz, H., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1249 · Cited by 137
Willmott, C., Critchlow, S. E., Eperon, I. C., & Maxwell, A. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1586 · Cited by 136
Hiasa, H., Yousef, D. O., & Marians, K. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26424 · Cited by 136
Efflux Pump Lde Is Associated with Fluoroquinolone Resistance in Listeria monocytogenes
Godreuil, S., Galimand, M., Gerbaud, G., Jacquet, C., & Courvalin, P. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.704-708.2003 · Cited by 135
High levels of multidrug resistance in clinical isolates of Gram-negative pathogens from Nigeria
Ogbolu, D. O., Daini, O., Ogunledun, A., Alli, O. A. T., & Webber, M. A. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2010.08.019 · Cited by 131
Mechanisms of Quinolone Resistance
Hooper, D. C. (2014) · ASM Press eBooks · doi:10.1128/9781555817817.ch3 · Cited by 128
Self-citationLi, X.-Z. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.6.885 · Cited by 124
MexZ-mediated regulation of multidrug efflux pump expression in by binding on the intergenic DNA
MATSUO, Y., EDA, S., Gotoh, N., Yoshihara, E., & Nakae, T. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.07.010 · Cited by 122
The Lactococcal lmrP Gene Encodes a Proton Motive Force- dependent Drug Transporter
Bolhuis, H., Poelarends, G. J., van Veen, H. W., Poolman, B., Driessen, A. J. M., & Konings, W. N. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26092 · Cited by 121
Miyamae, S., Ueda, O., Yoshimura, F., Hwang, J., Tanaka, Y., & Nikaido, H. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3341-3346.2001 · Cited by 119
Pan, X.-S., & Fisher, L. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1129 · Cited by 119
Montero, C. I., Mateu, G., Rodríguez, R., & Takiff, H. E. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3387-3392.2001 · Cited by 117
Yang, S. T. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg126 · Cited by 116
Sánchez, M. B., Hernández, A., Rodríguez-Martínez, J. M., Martínez-Martínez, L., & Martínez, J. L. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-148 · Cited by 114
Fournier, B., Zhao, X., Lu, T., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2160-2165.2000 · Cited by 112
Plasmid-mediated quinolone resistance in Aeromonas allosaccharophila recovered from a Swiss lake
Picão, R. C., Poirel, L., Demarta, A., Silva, C. S. F., Corvaglia, A., Petrini, O., & Nordmann, P. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn341 · Cited by 111
NewqnrGene Cassettes Associated with Superintegron Repeats inVibrio choleraeO1
da Fonseca, É. L., Freitas, F. D. S., Vieira, V. V., & Vicente, A. C. P. (2008) · Emerging infectious diseases · doi:10.3201/eid1407.080132 · Cited by 110
Miller, P. F., Gambino, L. F., Sulavik, M. C., & Gracheck, S. J. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1773 · Cited by 109
Citrobacter spp. as a Source of qnrB Alleles
Jacoby, G. A., Griffin, C. M., & Hooper, D. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05187-11 · Cited by 107
Self-citationYu, J., Grinius, L., & Hooper, D. C. (2002) · Journal of Bacteriology · doi:10.1128/jb.184.5.1370-1377.2002 · Cited by 103
Self-citationClinical Importance and Epidemiology of Quinolone Resistance
Kim, E. S., & Hooper, D. C. (2014) · Infection and Chemotherapy · doi:10.3947/ic.2014.46.4.226 · Cited by 101
Self-citationTruong, Q. C., & Hooper, D. C. (2007) · Journal of Bacteriology · doi:10.1128/jb.01819-06 · Cited by 101
Self-citationTruong, Q. C., & Hooper, D. C. (2010) · Journal of Bacteriology · doi:10.1128/jb.00018-10 · Cited by 100
Self-citationOteo, J., Cuevas, Ó., Lopez-Rodriguez, I., Banderas-Florido, A., Vindel, A., Pérez-Vázquez, M. D., Bautista, V., Arroyo, M., García-Caballero, J., Marín‐Casanova, P., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp211 · Cited by 97
Temporal Appearance of Plasmid-Mediated Quinolone Resistance Genes
Jacoby, G. A., Gacharna, N., Black, T. A., Miller, G. H., & Hooper, D. C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01447-08 · Cited by 96
Self-citationKaatz, G. W., DeMarco, C. E., & Seo, S. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1276-1281.2006 · Cited by 94
Aldred, K. J., McPherson, S. A., Wang, P., et al. (2011) · Biochemistry · doi:10.1021/bi2013905 · Cited by 92
Xiong, X., Bromley, E. H. C., Oelschlaeger, P., Woolfson, D. N., & SPENCER, J. M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1296 · Cited by 92
Weigel, L. M., Anderson, G. J., Facklam, R. R., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3517-3523.2001 · Cited by 84
Structure of QnrB1, a Plasmid-mediated Fluoroquinolone Resistance Factor
Vetting, M. W., Hegde, S. S., Wang, M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.226936 · Cited by 83
Wentzell, L. M., & Maxwell, A. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4266 · Cited by 83
Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr
Klyachko, K. A., Schuldiner, S., & Neyfakh, A. A. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.7.2189-2193.1997 · Cited by 83
Plasmid-Mediated OqxAB Is an Important Mechanism for Nitrofurantoin Resistance in Escherichia coli
Ho, P., Ng, K.-Y., Lo, W.-U., Law, P. Y.-T., Lai, E. L.-Y., Wang, Y., & Chow, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02156-15 · Cited by 82
Truong, Q. C., Ding, Y., & Hooper, D. C. (2008) · Journal of Bacteriology · doi:10.1128/jb.01068-08 · Cited by 81
Self-citationPiddock, L. J. V., Walters, R. N., & Diver, J. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.12.2331 · Cited by 78
mvaTmutation modifies the expression of thePseudomonas aeruginosamultidrug efflux operonmexEF-oprN
Westfall, L. W., Carty, N. L., Layland, N., Kuan, P. J., Colmer‐Hamood, J. A., & Hamood, A. N. (2006) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2005.00075.x · Cited by 77
Enzyme structural plasticity and the emergence of broad‐spectrum antibiotic resistance
Maurice, F., Broutin, I., Podglajen, I., Bénas, P., Collatz, E., & Dardel, F. (2008) · EMBO Reports · doi:10.1038/embor.2008.9 · Cited by 75
Rodríguez-Martínez, J. M., Velasco, C., Garcı́a, I., Cano, M. E., Martı́nez-Martı́nez, L., & Pascual, Á. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01444-06 · Cited by 75
Boncoeur, É., Durmort, C., Bernay, B., Ebel, C., Guilmi, A. M. D., Croizé, J., Vernet, T., & Jault, J. (2012) · Biochemistry · doi:10.1021/bi300762p · Cited by 73
Hay, T. J. M., Fraud, S., Lau, C. H., Gilmour, C., & Poole, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056858 · Cited by 71
Laponogov, I., Veselkov, D. A., Crevel, I. M.-T. C., Pan, X.-S., Fisher, L. M., & Sanderson, M. R. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt749 · Cited by 69
Zhao, L., Zhang, J., Zheng, B., Wei, Z., Shen, P., Li, S., Li, L., & Xiao, Y. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02594-14 · Cited by 69
Strahilevitz, J., & Hooper, D. C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1949-1956.2005 · Cited by 67
Self-citationQnr-like pentapeptide repeat proteins in Gram-positive bacteria
Rodríguez-Martínez, J. M., Velasco, C., Briales, A., García, I., Conejo, M. C., & Pascual, Á. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn115 · Cited by 67
Kumaraswami, M., Schuman, J. T., Seo, S. M., Kaatz, G. W., & Brennan, R. G. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1046 · Cited by 66
Cesaro, A., Bettoni, R. R. D., Lascols, C., Mérens, A., Soussy, C., & Cambau, E. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkn077 · Cited by 66
Nakaminami, H., Noguchi, N., & Sasatsu, M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01065-09 · Cited by 64
Yamada, Y., Hideka, K.-I., Shiota, S., Kuroda, T., & Tsuchiya, T. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.554 · Cited by 63
Guérin, F., Galimand, M., Tuambilangana, F., Courvalin, P. M., & Cattoir, V. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106340 · Cited by 61
bmr3, a third multidrug transporter gene of Bacillus subtilis
Ohki, R., & Murata, M. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.4.1423-1427.1997 · Cited by 56
Guillard, T., Grillon, A., de Champs, C., Cartier, C., Madoux, J., Berçot, B., Lebreil, A.-L., Lozniewski, A., Riahi, J., Vernet-Garnier, V., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087801 · Cited by 55
Fernando, D. M., Xu, W. W., Loewen, P. C., Zhanel, G. G., & Kumar, A. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03074-14 · Cited by 54
Jakobsen, L., Cattoir, V., Jensen, K. S., Hammerum, A. M., Nordmann, P., & Frimodt‐Møller, N. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks224 · Cited by 53
Ribeiro, T. G., Novais, Â., Branquinho, R., Machado, E., & Peixe, L. M. S. V. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00027-15 · Cited by 50
Hegde, S. S., Vetting, M. W., Mitchenall, L. A., Maxwell, A., & Blanchard, J. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01158-10 · Cited by 50
Hearnshaw, S. J., Edwards, M. J., Stevenson, C. E. M., Lawson, D. M., & Maxwell, A. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.02.017 · Cited by 46
Epidemiology of qnrVC alleles and emergence out of the Vibrionaceae family
da Fonseca, É. L., & Vicente, A. C. P. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.062661-0 · Cited by 45
Belotti, P.-T., Thabet, L., Laffargue, A., André, C., Coulange, L., Arpin, C., Messadi, A. A., M'Zali, F. H., Quentin, C., & Dubois, V. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv103 · Cited by 44
Rodríguez-Martínez, J. M., Pichardo, C., García, I., Pachón-Ibáñez, M. E., Docobo-Pérez, F., Pascual, Á., Pachón, J., & Martínez-Martínez, L. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02020.x · Cited by 43
Fluoroquinolone Efflux in Streptococcus suis Is Mediated by SatAB and Not by SmrA
Escudero, J. A., Millán, Á. S., Gutiérrez‐Gutiérrez, B., Hidalgo, L., Ragione, R. M. L., AbuOun, M., Galimand, M., Ferrándiz, M.-J., Domínguez, L., de la Campa, A. G., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00498-11 · Cited by 39
Lewin, C. S., Howard, B. M. A., & Smith, J. T. (1991) · Journal of Medical Microbiology · doi:10.1099/00222615-34-1-19 · Cited by 37
Hiasa, H. (2002) · Biochemistry · doi:10.1021/bi026352v · Cited by 36
Poelarends, G. J., Mazurkiewicz, P., Putman, M., Cool, R. H., van Veen, H. W., & Konings, W. N. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0173 · Cited by 34
Habeeb, M., Haque, A., Iversen, A., & Giske, C. G. (2013) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-013-1970-1 · Cited by 31
Molecular Basis for the Differential Quinolone Susceptibility of Mycobacterial DNA Gyrase
Kumar, R., Madhumathi, B. S., & Nagaraja, V. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01958-13 · Cited by 28
Boulund, F., Johnning, A., Pereira, M. B., Larsson, D. G. J., & Kristiansson, E. (2012) · BMC Genomics · doi:10.1186/1471-2164-13-695 · Cited by 27
Sabtcheva, S., Kaku, M., Saga, T., Ishii, Y., & Kantardjiev, T. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00584-08 · Cited by 24
Characterization of Tn 6238 with a New Allele of aac(6′)-Ib-cr
Quiroga, M. P., Orman, B. E., Errecalde, L., Kaufman, S. C., & Centrón, D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03213-14 · Cited by 11
Barbosa, T. M., & Pomposiello, P. J. (2014) · ASM Press eBooks · doi:10.1128/9781555817572.ch15 · Cited by 6
Cited by
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
Pham, T. D. M., Ziora, Z. M., & Blaskovich, M. A. T. (2019) · MedChemComm · doi:10.1039/c9md00120d · Cited by 785
Staphylococcus aureus: A Review of the Pathogenesis and Virulence Mechanisms
Touaitia, R., Mairi, A., Ibrahim, N. A., Basher, N. S., Idres, T., & Touati, A. (2025) · Antibiotics · doi:10.3390/antibiotics14050470 · Cited by 273
Kent, A. G., Vill, A. C., Shi, Q., Satlin, M. J., & Brito, I. L. (2020) · Nature Communications · doi:10.1038/s41467-020-18164-7 · Cited by 216
Structural assembly of the bacterial essential interactome
Gómez Borrego, J., & Torrent Burgas, M. (2024) · eLife · doi:10.7554/elife.94919 · Cited by 16
Metadata
- Authors
- Hooper, D. C., & Jacoby, G. A.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-07-22
- Volume
- 6
- Issue
- 9
- Pages
- a025320
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2498876603
- Cited by
- 553
- References
- 158
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.